After completing this activity, the participant should be better able to:
- Discuss the results of basic and clinical ophthalmology investigations and vision research underway, relevant to my area of interest or practice.
- Describe new models and methods being used by researchers and practitioners in eye and vision science.
- Cite ways in which new research data and methods may influence my research and/or practice.
- Discuss prospective advancements in eye and vision research and/or practice.
The following Annual Meeting session types are not eligible for AMA PRA Category 1 Credits™: ALCON/Keynote series, Award lectures, Posters, SiGs, and Special sessions. All other session types are considered for inclusion in the CME program.
The Association for Research in Vision and Ophthalmology (ARVO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician credit designation
ARVO designates this live activity for 29.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
International Attendees: The American Medical Association (AMA) has determined that physicians not licensed in the U.S. who participate in CME activities are eligible for AMA PRA Category 1 Credit™.
American Board of Ophthalmology (ABO) Diplomates
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning, Self-Assessment, Improvement in Medical Practice and/or Patient Safety requirements for the American Board of Ophthalmology’s Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting MOC credit.
The Annual Meeting qualifies for Lifelong Learning (Part II). Credits will be reported to the ABO via the ACCME in September each year.
ARVO does not solicit commercial support so learner data will not be shared with any entity other than the ACCME for the purpose of reporting MOC credit. Attendees will be able to provide the required information for MOC credit reporting on the Overall Meeting Evaluation Form. By providing the required information, attendees will be giving ARVO permission to share their learner data with the ACCME.
Royal College of Physicians and Surgeons of Canada
Fellows and Health Care Professionals participating in the Maintenance of Certification Program can record credits earned at the Annual Meeting toward Section 1: Group Learning Credits.
European Union of Medical Specialists (UEMS) CME/CPD Requirements
European physicians can convert CME credit from the Annual Meeting to meet European Union of Medical Specialists (UEMS) CME/CPD requirements.
The American Medical Association has an agreement of mutual recognition of CME credits with the UEMS, the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at email@example.com.
Certificate of Participation
ARVO is accredited to offer AMA PRA Category 1 Credits™ to physicians. All other participants in the CME program may receive a Certificate of Participation that documents the number of CME hours attended* by following the same instructions listed above and paying the CME credits and certificates fee.
*Some accrediting agencies may award equivalent Continuing Education (CE) credit when presented with a Certificate of Participation from an activity that offered AMA PRA Category 1 Credit™. Check with your accrediting agency for information.
Instructions to receive credit and/or certificates
Attendees interested in claiming AMA PRA Category 1 Credits™ for attendance at the Annual Meeting must pay the CME credits and certificates fee. Payment is collected during the registration process by adding “CME credits and certificates” as a session. Attendees who do not register for CME before the conclusion of the meeting will not be able to claim and request credit. Attendees registered as guests are not eligible to receive CME credit.
CME registrants will receive an email from “ARVO 2019 CME” with credit claiming instructions prior to the start of the Annual Meeting or within two business days of your purchase (whichever is later). All requests for credit must be submitted no later than 11:59pm U.S. Eastern Time on Friday, Aug. 30, 2019.
CME credits and certificates fee (must be paid no later than May 2, 2019).
|Registration type||In advance||Onsite|
|MIT, Student Nonmember||$59||$59|
|Member, Nonmember, Exhibitor (paid full meeting access badge)||$79||$99|
|Exhibitor (complimentary full meeting access badge only)||$89||$89|
Certificate of attendance
Certificates of attendance are available free to all attendees. These certificates state that one has attended the Annual Meeting; but does not offer credit tracking. They will be available onsite at the Meeting registration desk and ARVO Central in the exhibit hall.
The Annual Meeting provides a forum for the open exchange and discussion of research results and scientific advancements in the field of ophthalmology; however, ARVO makes no representation or warranty as to the truth, originality, or accuracy of the information presented at the meeting or in materials distributed in connection with them. Nor are the views expressed by the individual speakers necessarily the views of ARVO. ARVO supports the ACCME’s policy on evidence-based content and encourages faculty to adhere to these standards when planning a presentation.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this meeting is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclaimer off-label use
The Annual Meeting may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ARVO does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Disclosure of conflicts of interest
ARVO requires instructors, planners, managers and other individuals and their spouse/ partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ARVO for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Disclosure information for faculty is provided within initial disclosure slides, prior to the start of their respective presentations and within the online planner, mobile app and Commercial Relationships Index. Disclosure for all individuals involved in planning and managing this CME activity are listed in the Pocket Guide with their relevant disclosure information.
For information about the accreditation of this program, please contact us at p. 1+240-221-2900 or firstname.lastname@example.org.